JPWO2020218577A1 - - Google Patents
Info
- Publication number
- JPWO2020218577A1 JPWO2020218577A1 JP2021516304A JP2021516304A JPWO2020218577A1 JP WO2020218577 A1 JPWO2020218577 A1 JP WO2020218577A1 JP 2021516304 A JP2021516304 A JP 2021516304A JP 2021516304 A JP2021516304 A JP 2021516304A JP WO2020218577 A1 JPWO2020218577 A1 JP WO2020218577A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019086554 | 2019-04-26 | ||
| PCT/JP2020/017837 WO2020218577A1 (ja) | 2019-04-26 | 2020-04-24 | フラビウイルス感染症治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2020218577A1 true JPWO2020218577A1 (https=) | 2020-10-29 |
Family
ID=72942078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021516304A Pending JPWO2020218577A1 (https=) | 2019-04-26 | 2020-04-24 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220193124A1 (https=) |
| EP (1) | EP3960241A4 (https=) |
| JP (1) | JPWO2020218577A1 (https=) |
| CN (1) | CN113747946B (https=) |
| TW (1) | TW202106293A (https=) |
| WO (1) | WO2020218577A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7497790B2 (ja) * | 2019-12-27 | 2024-06-11 | 国立大学法人北海道大学 | 豚コレラの治療及び／又は予防剤 |
| JPWO2021215517A1 (https=) * | 2020-04-22 | 2021-10-28 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011003071A1 (en) * | 2009-07-02 | 2011-01-06 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods of modulating hepatitis c virus infection |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5234940A (en) * | 1989-07-28 | 1993-08-10 | Queen's University | Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof |
| US5895786A (en) * | 1996-05-08 | 1999-04-20 | New York Blood Center, Inc. | Method for treating viral infections |
| JP4417865B2 (ja) | 2004-03-30 | 2010-02-17 | コスモ石油株式会社 | ５−アミノレブリン酸リン酸塩、その製造方法及びその用途 |
| JP4520219B2 (ja) | 2004-05-28 | 2010-08-04 | 協和発酵バイオ株式会社 | ５−アミノレブリン酸の製造法 |
| GB0700580D0 (en) | 2007-01-11 | 2007-02-21 | Photocure Asa | Use |
| WO2014013664A1 (ja) | 2012-07-19 | 2014-01-23 | Ｓｂｉファーマ株式会社 | インフルエンザウイルス感染症の予防・治療剤 |
| HK1246682A1 (en) | 2015-04-10 | 2018-09-14 | Sbi Pharmaceuticals Co., Ltd. | Prophylactic/therapeutic agent for virus infections which comprises ala compound |
| WO2019059027A1 (ja) * | 2017-09-19 | 2019-03-28 | ネオファーマジャパン株式会社 | ５－アミノレブリン酸を含むエビ目用組成物 |
-
2020
- 2020-04-24 JP JP2021516304A patent/JPWO2020218577A1/ja active Pending
- 2020-04-24 EP EP20795639.2A patent/EP3960241A4/en not_active Withdrawn
- 2020-04-24 CN CN202080031534.4A patent/CN113747946B/zh not_active Expired - Fee Related
- 2020-04-24 TW TW109113893A patent/TW202106293A/zh unknown
- 2020-04-24 US US17/606,413 patent/US20220193124A1/en not_active Abandoned
- 2020-04-24 WO PCT/JP2020/017837 patent/WO2020218577A1/ja not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011003071A1 (en) * | 2009-07-02 | 2011-01-06 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods of modulating hepatitis c virus infection |
Non-Patent Citations (7)
| Title |
|---|
| ESPINOZA J ET AL.: "Modulation of Antiviral Immunity by Heme Oxygenase-1", AM J PATHOL, vol. 187, no. 3, JPN6020021950, 2017, pages 487 - 493, ISSN: 0005369299 * |
| ITO H ET AL.: "Oral administration of 5-aminolevulinic acid induces heme oxygenase-1 expression in peripheral blood", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 833, JPN6020021944, 2018, pages 25 - 33, ISSN: 0005369296 * |
| KALAMOUNI C ET AL.: "Subversion of the Heme Oxygenase-1 Antiviral Activity by Zika Virus", VIRUSES, vol. 11,2, JPN6020021951, 2018, pages 1 - 13, ISSN: 0005369300 * |
| LEE B. J. ET AL.: "Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinicacid and its", BRITISH JOURNAL OF DERMATOLOGY, vol. 159, JPN6020021956, 2008, pages 61 - 67, ISSN: 0005369302 * |
| SAITO K ET AL.: "Dynamics of absorption, metabolism, and excretion of 5-aminolevulinic acid in human intestinal Caco-", BIOCHEMISTRY AND BIOPHYSICS REPORTS, vol. 11, JPN6020021948, 2017, pages 105 - 111, ISSN: 0005369298 * |
| ZHAO M ET AL.: "5-Aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hy", AM J PHYSIOL CELL PHYSIOL, vol. 308, JPN6020021946, 2015, pages 665 - 672, ISSN: 0005369297 * |
| 合阪幸三: "子宮内膜症の治療 薬物療法 アドバック療法", 日本臨床, vol. 増刊号1, JPN6020021954, 2001, pages 129 - 132, ISSN: 0005369301 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3960241A4 (en) | 2023-06-07 |
| US20220193124A1 (en) | 2022-06-23 |
| EP3960241A1 (en) | 2022-03-02 |
| WO2020218577A1 (ja) | 2020-10-29 |
| TW202106293A (zh) | 2021-02-16 |
| CN113747946B (zh) | 2023-08-29 |
| CN113747946A (zh) | 2021-12-03 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20220126 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220128 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230314 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240119 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240712 |